These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5336514)

  • 1. [A homeotherapeutic double-blind experiment and its problems].
    Ritter H
    Hippokrates; 1966 Jun; 37(12):472-6. PubMed ID: 5336514
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect and tolerance of a gall-enzyme preparation].
    Gross W; Kaiser HJ
    Med Welt; 1978 Jan; 29(4):144-9. PubMed ID: 345040
    [No Abstract]   [Full Text] [Related]  

  • 3. [How are negative controlled clinical studies interpreted? A 10-year randomized hepato-gastro-enterological study with insignificant results].
    Juhl E; Christensen E; Tygstrup N
    Ugeskr Laeger; 1982 Oct; 144(40):2913-8. PubMed ID: 7179562
    [No Abstract]   [Full Text] [Related]  

  • 4. The ethics of phase I trials of biologic agents.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2008 Oct; 5(10):533. PubMed ID: 18827830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
    Feu F; Bosch J
    Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology of gastrointestinal and liver disease. Preface.
    Hunt RH
    Gastroenterol Clin North Am; 2010 Sep; 39(3):xv-xvi. PubMed ID: 20951908
    [No Abstract]   [Full Text] [Related]  

  • 7. Relief of functional gastrointestinal complaints associated with gaseousness: a double-blind crossover study.
    Bobruff J
    Am J Proctol; 1968 Jun; 19(3):191-6. PubMed ID: 4872928
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effects of Diromo on intestinal diseases (studies by double blind test)].
    Morisawa T
    Naika Hokan; 1970 Apr; 17(4):99-102. PubMed ID: 4916328
    [No Abstract]   [Full Text] [Related]  

  • 9. [New treatment possibilities in gastrointestinal diseases: bromoprid].
    Krapf W
    Med Klin; 1980 Oct; 75(22):790-1. PubMed ID: 7005632
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with a new hepatoprotector].
    Rocca F
    Clin Ter; 1969 Jun; 49(5):473-8. PubMed ID: 5386746
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical double-blind trial with a broad spectrum digestive enzyme product ("Combizym") in geriatric practice.
    Kataria MS; Bhaskarrao D
    Br J Clin Pract; 1969 Jan; 23(1):15-7. PubMed ID: 4884205
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of enzyme therapy on food tolerance and digestive disorders].
    Gullatz P
    Landarzt; 1968 Nov; 44(33):1635-8. PubMed ID: 5717136
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta-blockers in gastroenterology and hepatology].
    Malè PJ
    Rev Med Suisse Romande; 1984 Mar; 104(3):203-6. PubMed ID: 6144157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
    Machalke K; Müller B
    Fortschr Med; 1982 Apr; 100(14):665-7. PubMed ID: 6123478
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders.
    Dhar A; Chawla YK
    Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experimentation with a new hepatotropic agent, EU 2200].
    Linquette M; Decoulx M
    Lille Med; 1966 Nov; 11(9):1051-5. PubMed ID: 5994072
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E
    Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical research on the hepatoprotective and antianemic action of hepatic opotherapy associated with nucleosides in high doses].
    Bestagno M
    Arch Maragliano Patol Clin; 1966; 22(3):299-309. PubMed ID: 5953073
    [No Abstract]   [Full Text] [Related]  

  • 19. [The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
    Riva D; Manieri L; Mariano P
    Arch Sci Med (Torino); 1980; 137(3):461-6. PubMed ID: 6112973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hepato-biliary diseases in children and adults by a drug composed of orotic acid and sorbitol].
    Cachin M; Alagille D
    Presse Med (1893); 1967 Apr; 75(17):859-60. PubMed ID: 6021371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.